Symbols / AMPE $0.18 +0.00% Ampio Pharmaceuticals, Inc.
AMPE Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteAmpio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
Ratings
Current target
$0.18
Low
—
High
—
Mean
—
- Ampio Announces Voluntary Delisting and SEC Deregistration - PR Newswire Mon, 25 Mar 2024 07
- Ampio Pharma (AMPE) Stock News & Updates - Stock Titan Fri, 24 Jul 2020 14
- AMPE Stock Price and Chart — OTC:AMPE - TradingView Sun, 09 Oct 2022 05
- Ampio Pharmaceuticals Stock Price Forecast. Should You Buy AMPE? - StockInvest.us ue, 01 Dec 2020 14
- Ampio Pharmaceuticals to delist from NYSE American - Investing.com Mon, 25 Mar 2024 07
- AMPE Stock Price, News & Analysis | Ampio Pharma - Stock Titan hu, 24 Apr 2025 22
- Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis $AMPE - MarketBeat Wed, 14 Oct 2015 22
- These stocks are moving in today's after hours session - ChartMill Wed, 03 Aug 2022 07
- Ampio Pharmaceuticals Announces Reverse Stock Split - Nasdaq hu, 31 Aug 2023 07
- Which stocks are moving after the closing bell on Wednesday? - ChartMill Wed, 04 May 2022 07
- These stocks are gapping in today's session - ChartMill hu, 24 Mar 2022 07
- EFTR Stock Price, News & Analysis - Stock Titan Fri, 25 Apr 2025 00
- These stocks are moving in today's after hours session - ChartMill Fri, 18 Mar 2022 07
- Top movers in Tuesday's after hours session - ChartMill ue, 14 Sep 2021 07
- Top movers in Thursday's after hours session - ChartMill hu, 02 Jun 2022 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
9.52
-53.30%
|
20.38
-0.92%
|
20.57
|
| Research And Development |
|
2.44
-72.64%
|
8.92
-25.08%
|
11.90
|
| Selling General And Administration |
|
7.08
-38.26%
|
11.47
+32.23%
|
8.67
|
| General And Administrative Expense |
|
7.08
-38.26%
|
11.47
+32.23%
|
8.67
|
| Salaries And Wages |
|
1.52
-41.63%
|
2.61
-38.55%
|
4.25
|
| Other Gand A |
|
4.59
-40.62%
|
7.73
+138.91%
|
3.24
|
| Total Expenses |
|
9.52
-53.30%
|
20.38
-0.92%
|
20.57
|
| Operating Income |
|
-9.52
+53.30%
|
-20.38
+0.92%
|
-20.57
|
| EBITDA |
|
-9.40
+51.40%
|
-19.33
+0.73%
|
-19.48
|
| Normalized EBITDA |
|
-9.34
+59.67%
|
-23.16
-0.83%
|
-22.97
|
| Reconciled Depreciation |
|
0.12
-88.36%
|
1.05
-4.20%
|
1.09
|
| EBIT |
|
-9.52
+53.30%
|
-20.38
+0.92%
|
-20.57
|
| Total Unusual Items |
|
-0.06
-101.46%
|
3.83
+9.54%
|
3.49
|
| Total Unusual Items Excluding Goodwill |
|
-0.06
-101.46%
|
3.83
+9.54%
|
3.49
|
| Special Income Charges |
|
-0.06
+97.11%
|
-1.94
|
0.00
|
| Impairment Of Capital Assets |
|
0.00
-100.00%
|
1.94
|
0.00
|
| Net Income |
|
-8.63
+47.16%
|
-16.34
+4.32%
|
-17.07
|
| Pretax Income |
|
-8.63
+47.16%
|
-16.34
+4.32%
|
-17.07
|
| Net Non Operating Interest Income Expense |
|
0.35
+58.18%
|
0.22
+5400.00%
|
0.00
|
| Net Interest Income |
|
0.35
+58.18%
|
0.22
+5400.00%
|
0.00
|
| Interest Income Non Operating |
|
0.35
+58.18%
|
0.22
+5400.00%
|
0.00
|
| Interest Income |
|
0.35
+58.18%
|
0.22
+5400.00%
|
0.00
|
| Other Income Expense |
|
0.54
-85.93%
|
3.83
+9.54%
|
3.49
|
| Other Non Operating Income Expenses |
|
0.59
|
—
|
—
|
| Gain On Sale Of Security |
|
—
|
5.76
+64.98%
|
3.49
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-8.63
+47.16%
|
-16.34
+4.32%
|
-17.07
|
| Net Income From Continuing Operation Net Minority Interest |
|
-8.63
+47.16%
|
-16.34
+4.32%
|
-17.07
|
| Net Income From Continuing And Discontinued Operation |
|
-8.63
+47.16%
|
-16.34
+4.32%
|
-17.07
|
| Net Income Continuous Operations |
|
-8.63
+47.16%
|
-16.34
+4.32%
|
-17.07
|
| Normalized Income |
|
-8.58
+57.46%
|
-20.16
+1.97%
|
-20.57
|
| Net Income Common Stockholders |
|
-8.63
+47.16%
|
-16.34
+4.32%
|
-17.07
|
| Diluted EPS |
|
—
|
-29.32
+2.27%
|
-30.00
|
| Basic EPS |
|
—
|
-21.68
+19.70%
|
-27.00
|
| Basic Average Shares |
|
—
|
0.75
+13.44%
|
0.66
|
| Diluted Average Shares |
|
—
|
0.75
+10.31%
|
0.68
|
| Diluted NI Availto Com Stockholders |
|
-8.63
+60.94%
|
-22.10
-29.42%
|
-17.07
|
| Average Dilution Earnings |
|
0.00
+100.00%
|
-5.76
|
—
|
| Depreciation Amortization Depletion Income Statement |
|
—
|
—
|
0.02
|
| Depreciation And Amortization In Income Statement |
|
—
|
—
|
0.02
|
| Depreciation Income Statement |
|
—
|
—
|
0.02
|
| Gain On Sale Of PPE |
|
-0.06
|
0.00
|
0.00
|
| Insurance And Claims |
|
0.96
-14.23%
|
1.12
-5.23%
|
1.19
|
| Line Item | Trend | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Assets |
|
5.74
-57.79%
|
13.59
-65.00%
|
38.83
|
| Current Assets |
|
5.74
-56.97%
|
13.33
-62.59%
|
35.63
|
| Cash Cash Equivalents And Short Term Investments |
|
4.09
-67.68%
|
12.65
-62.67%
|
33.89
|
| Cash And Cash Equivalents |
|
4.09
-67.68%
|
12.65
-62.67%
|
33.89
|
| Receivables |
|
0.92
|
0.00
-100.00%
|
0.02
|
| Other Receivables |
|
0.92
|
—
|
0.02
|
| Inventory |
|
—
|
0.00
-100.00%
|
0.07
|
| Prepaid Assets |
|
0.25
+632.35%
|
0.03
-96.96%
|
1.12
|
| Current Deferred Assets |
|
0.14
|
0.00
|
—
|
| Other Current Assets |
|
0.34
-46.73%
|
0.64
+16.94%
|
0.55
|
| Total Non Current Assets |
|
0.00
-100.00%
|
0.26
-91.89%
|
3.19
|
| Net PPE |
|
0.00
-100.00%
|
0.26
-91.89%
|
3.19
|
| Gross PPE |
|
0.00
-100.00%
|
9.50
-16.83%
|
11.43
|
| Accumulated Depreciation |
|
0.00
+100.00%
|
-9.24
-12.28%
|
-8.23
|
| Properties |
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.00
-100.00%
|
4.54
-15.19%
|
5.35
|
| Other Properties |
|
—
|
—
|
0.24
|
| Leases |
|
0.00
-100.00%
|
4.96
-18.27%
|
6.08
|
| Total Liabilities Net Minority Interest |
|
2.38
+32.07%
|
1.80
-84.41%
|
11.54
|
| Current Liabilities |
|
2.38
+99.33%
|
1.19
-76.73%
|
5.12
|
| Payables And Accrued Expenses |
|
2.10
+196.47%
|
0.71
-83.97%
|
4.42
|
| Payables |
|
0.83
+234.94%
|
0.25
-41.69%
|
0.43
|
| Accounts Payable |
|
0.75
+673.20%
|
0.10
-77.28%
|
0.43
|
| Other Payable |
|
0.06
|
—
|
—
|
| Current Accrued Expenses |
|
1.27
+175.65%
|
0.46
-88.49%
|
4.00
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.00
-100.00%
|
0.14
-63.24%
|
0.39
|
| Total Tax Payable |
|
0.02
-85.53%
|
0.15
|
—
|
| Current Debt And Capital Lease Obligation |
|
0.27
-19.41%
|
0.34
+9.32%
|
0.31
|
| Current Capital Lease Obligation |
|
0.27
-19.41%
|
0.34
+9.32%
|
0.31
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
-100.00%
|
0.61
-90.54%
|
6.42
|
| Long Term Debt And Capital Lease Obligation |
|
0.00
-100.00%
|
0.27
-55.37%
|
0.61
|
| Long Term Capital Lease Obligation |
|
0.00
-100.00%
|
0.27
-55.37%
|
0.61
|
| Long Term Provisions |
|
—
|
0.29
|
—
|
| Stockholders Equity |
|
3.36
-71.50%
|
11.79
-56.79%
|
27.28
|
| Common Stock Equity |
|
3.36
-71.50%
|
11.79
-56.79%
|
27.28
|
| Capital Stock |
|
0.00
|
0.00
-100.00%
|
0.00
|
| Common Stock |
|
0.00
|
0.00
-100.00%
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
0.83
+10.37%
|
0.76
-93.36%
|
11.37
|
| Ordinary Shares Number |
|
0.83
+10.37%
|
0.76
-93.36%
|
11.37
|
| Additional Paid In Capital |
|
245.89
+0.06%
|
245.73
+0.34%
|
244.88
|
| Retained Earnings |
|
-242.53
-3.67%
|
-233.94
-7.51%
|
-217.60
|
| Total Equity Gross Minority Interest |
|
3.36
-71.50%
|
11.79
-56.79%
|
27.28
|
| Total Capitalization |
|
3.36
-71.50%
|
11.79
-56.79%
|
27.28
|
| Working Capital |
|
3.36
-72.32%
|
12.14
-60.22%
|
30.51
|
| Invested Capital |
|
3.36
-71.50%
|
11.79
-56.79%
|
27.28
|
| Total Debt |
|
0.27
-55.37%
|
0.61
-33.62%
|
0.93
|
| Capital Lease Obligations |
|
0.27
-55.37%
|
0.61
-33.62%
|
0.93
|
| Net Tangible Assets |
|
3.36
-71.50%
|
11.79
-56.79%
|
27.28
|
| Tangible Book Value |
|
3.36
-71.50%
|
11.79
-56.79%
|
27.28
|
| Derivative Product Liabilities |
|
0.00
-100.00%
|
0.04
-99.24%
|
5.80
|
| Other Inventories |
|
—
|
—
|
0.07
|
| Line Item | Trend | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow |
|
-8.56
+59.47%
|
-21.13
-49.96%
|
-14.09
|
| Cash Flow From Continuing Operating Activities |
|
-8.56
+59.47%
|
-21.13
-49.96%
|
-14.09
|
| Net Income From Continuing Operations |
|
-8.63
+47.16%
|
-16.34
+4.32%
|
-17.07
|
| Depreciation Amortization Depletion |
|
0.12
-88.36%
|
1.05
-4.20%
|
1.09
|
| Depreciation And Amortization |
|
0.12
-88.36%
|
1.05
-4.20%
|
1.09
|
| Other Non Cash Items |
|
-0.28
-4157.14%
|
0.01
-91.25%
|
0.08
|
| Stock Based Compensation |
|
0.16
-83.32%
|
0.95
-65.01%
|
2.72
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
1.94
|
0.00
|
| Operating Gains Losses |
|
0.06
+100.97%
|
-5.76
-64.98%
|
-3.49
|
| Gain Loss On Investment Securities |
|
—
|
-5.76
-64.98%
|
-3.49
|
| Gain Loss On Sale Of PPE |
|
0.06
|
0.00
|
0.00
|
| Change In Working Capital |
|
0.01
+100.50%
|
-2.97
-215.27%
|
2.58
|
| Change In Receivables |
|
-0.92
|
0.00
|
—
|
| Change In Prepaid Assets |
|
-0.05
-104.79%
|
1.06
+279.43%
|
-0.59
|
| Change In Payables And Accrued Expense |
|
1.25
+131.60%
|
-3.96
-221.37%
|
3.26
|
| Change In Other Current Liabilities |
|
-0.27
-235.44%
|
-0.08
+11.24%
|
-0.09
|
| Investing Cash Flow |
|
0.00
|
0.00
+100.00%
|
-0.10
|
| Cash Flow From Continuing Investing Activities |
|
—
|
0.00
+100.00%
|
-0.10
|
| Net PPE Purchase And Sale |
|
—
|
0.00
+100.00%
|
-0.10
|
| Purchase Of PPE |
|
—
|
0.00
+100.00%
|
-0.10
|
| Capital Expenditure |
|
—
|
—
|
-0.10
|
| Financing Cash Flow |
|
0.00
+100.00%
|
-0.11
-100.36%
|
30.73
|
| Cash Flow From Continuing Financing Activities |
|
0.00
+100.00%
|
-0.11
-100.36%
|
30.73
|
| Net Common Stock Issuance |
|
0.10
|
0.00
-100.00%
|
33.01
|
| Common Stock Payments |
|
—
|
—
|
-0.19
|
| Repurchase Of Capital Stock |
|
—
|
—
|
-0.19
|
| Proceeds From Stock Option Exercised |
|
—
|
0.00
-100.00%
|
0.23
|
| Net Other Financing Charges |
|
-0.10
+11.71%
|
-0.11
+95.58%
|
-2.51
|
| Changes In Cash |
|
-8.56
+59.68%
|
-21.24
-228.36%
|
16.55
|
| Beginning Cash Position |
|
12.65
-62.67%
|
33.89
+95.39%
|
17.35
|
| End Cash Position |
|
4.09
-67.68%
|
12.65
-62.67%
|
33.89
|
| Free Cash Flow |
|
-8.56
+59.47%
|
-21.13
-48.94%
|
-14.19
|
| Common Stock Issuance |
|
0.10
|
0.00
-100.00%
|
33.01
|
| Issuance Of Capital Stock |
|
0.10
|
0.00
-100.00%
|
33.01
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|